Upregulation of C/EBPα contributes to colorectal cancer growth, metastasis and indicates poor survival outcome

The function and clinical implication of transcription factor CCAAT/enhancer-binding protein α (C/EBPα) in colorectal cancer (CRC) still remains undefined. In fact, C/EBPα has long been considered as a tumor suppressor in hematopoietic system and also found lowly expressed in numerous solid tumors....

Full description

Saved in:
Bibliographic Details
Main Authors: Mi, Lan (Author) , Hu, Kai (Author) , Wen, Xianzi (Author) , Sun, Jing (Author) , Wu, Aiwen (Author) , Wang, Mingliang (Author) , Zheng, Minhua (Author) , Zang, Lu (Author) , Ji, Jiafu (Author)
Format: Article (Journal)
Language:English
Published: August 1, 2018
In: American journal of cancer research
Year: 2018, Volume: 8, Issue: 8, Pages: 1449-1465
ISSN:2156-6976
Online Access: Get full text
Author Notes:Lan Mi, Kai Hu, Xianzi Wen, Jing Sun, Aiwen Wu, Mingliang Wang, Minhua Zheng, Lu Zang, Jiafu Ji
Description
Summary:The function and clinical implication of transcription factor CCAAT/enhancer-binding protein α (C/EBPα) in colorectal cancer (CRC) still remains undefined. In fact, C/EBPα has long been considered as a tumor suppressor in hematopoietic system and also found lowly expressed in numerous solid tumors. However, our results here for the first time showed that C/EBPα was unexpectedly upregulated and was an independent prognostic marker for patients with CRC. We therefore aimed to explore the detailed role and mechanisms of C/EBPα in CRC. Our investigation demonstrated that C/EBPα promoted tumor growth both in vitro and in vivo. In addition, suppression of C/EBPα inhibited cell proliferation by inducing G1 phase arrest and inducing apoptosis. Also, C/EBPα enhances CRC cells migration and invasion in vitro as well as metastasis in vivo through regulating EMT. Mechanistically, C/EBPα exerts its oncogenic role by targeting c-Myc/cyclin D1 mediated by β-catenin involved pathway and we provide evidence indicating that cytoplasmic exclusion of C/EBPα might contribute to its oncogenic function in tumor progression. In conclusion, C/EBPα acts as an oncogene in CRC and could be a potential biomarker of colon carcinogenesis.
Item Description:Gesehen am 14.04.2020
Physical Description:Online Resource
ISSN:2156-6976